Webb7 apr. 2024 · Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate” or the "Company”) will hold its Annual General Meeting of Shareholders ("AGM”) at 10:30 a.m. CEST on May 12, 2024 in its ... Webb14 apr. 2024 · Innate Pharma has a 1 year low of $1.90 and a 1 year high of $3.97. The business’s 50 day simple moving average is $3.10 and its 200 day simple moving …
Innate Pharma files its 2024 universal registration document …
Webb7 apr. 2024 · Innate Pharma S.A. est une société de biotechnologies au stade clinique qui développe des traitements d'immunothérapies contre le cancer. Son approche innovante vise à tirer avantage du système... Webb11 dec. 2024 · Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through … buy tcl r646
Investor Relations Innate Pharma
Webb6 apr. 2024 · Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2024 Universal Registration Document (Document d’enregistrement universel) for the year ending December 31, 2024 with the French market authority “Autorité des Marchés Financiers” (“AMF”) on April 6, 2024. Webb16 aug. 2024 · This is where France-based biotech Innate Pharma comes in. As the company’s name suggests, Innate aims to “harness the function of the cells of the innate immune system, in order to launch protective immune responses against cancer” – and it has developed an innovative technology platform to achieve this. The advantages of NK … Webb6 apr. 2024 · Innate Pharma S.A. est une société de biotechnologies au stade clinique qui développe des traitements d'immunothérapies contre le cancer. Son approche innovante vise à tirer avantage du système... buy tcl 65 inch tv